Who is telopoietin suitable for? - Can this drug be used for your type of obesity?

Obesity not only affects appearance but is also a chronic metabolic disease closely associated with the risk of type 2 diabetes, hypertension, fatty liver, and cardiovascular disease . However, different types of obesity require different weight loss strategies , and traditional dieting, exercise, and even some weight loss drugs may not be effective for certain individuals.

In recent years, GLP-1 receptor agonists have become core drugs for obesity management . Among them , telpotetide, due to its dual agonist mechanism of GLP-1 + GIP , is considered the most potent FDA -approved weight-loss drug currently available . However, telpotetide is not suitable for everyone . So, who is most suitable to use this drug? Who is not suitable? This article will provide a detailed analysis of the suitable and contraindicated populations for telpotetide, as well as medication recommendations for different types of obesity , to help you make a scientific choice.

 

1. Who is suitable for telpoeptide?

📌 FDA -approved target population

✔ Adults with a BMI ≥30 (obese) : This applies to all obese patients, regardless of whether they have metabolic diseases.

✔ Adults with a BMI ≥27 and at least one weight-related condition (such as type 2 diabetes, hypertension, high cholesterol, obstructive sleep apnea, etc.).

✔ For individuals who wish to lose 15%-20% or more of their weight , clinical studies have shown that telpolide can reduce weight by an average of 22.5% over 72 weeks .

📌 Applicability to different types of obesity

Types of obesity	Is telpoeptide suitable?	Reasons for recommendation
Metabolic obesity (prediabetes, insulin resistance)	✅ Suitable	Telpoeptide can improve insulin sensitivity, lower blood sugar, and prevent type 2 diabetes.
Stubborn obesity (long-term dieting + exercise ineffective)	✅ Suitable	Traditional methods may be ineffective, but telpolide can reduce appetite and improve metabolism through hormone regulation.
Binge eating-related obesity (appetite disorder)	✅ Suitable	Telborpeptide acts on the hypothalamus appetite center to help control appetite.
Visceral fat obesity (abdominal fat accumulation)	✅ Suitable	Studies have shown that telpoeptide has a significant effect on reducing abdominal fat.
Age-related obesity (menopausal / elderly population)	✅ Suitable	It can improve weight gain caused by a decreased metabolic rate, but individual tolerance needs to be assessed.
Mildly overweight ( BMI 25-27 , no other diseases)	❌ Not recommended	For individuals not covered by the FDA , lifestyle interventions can be tried first if the condition is not at serious health risk.

💡 Conclusion: Telborpeptide is suitable for most obese or metabolically abnormal individuals, especially those who are unable to lose weight in the long term, but it is not recommended for mildly overweight individuals.

 

2. Who is telpolide not suitable for? (Contraindications)

Although telpolide has a high safety profile and is better tolerable than traditional GLP-1 drugs , it is still unsuitable for some people, mainly including the following groups:

📌 1. Patients with thyroid-related diseases

•       Those with medullary thyroid carcinoma ( MTC ) or a family history of the disease should not apply. Disable

•       Patients with multiple endocrine tumor syndrome type 2 ( MEN 2 ) ❌ Disable

•       Those with thyroid nodules or thyroid dysfunction ⚠ Doctor's evaluation required

📌 Reason : Telboride has been shown to increase the risk of thyroid C- cell hyperplasia in animal studies, but this has not been confirmed in human studies. Therefore, it is contraindicated in patients with MTC and MEN 2 .

📌 2. Pregnant women, breastfeeding women, and women planning to conceive

•       Pregnant women and those planning to become pregnant ❌ Disable

•       Breastfeeding women⚠ Doctor's evaluation required

📌 Reason : GLP-1 drugs may affect fetal growth, and it is recommended to stop taking them at least 2 months before planning pregnancy .

📌 3. Patients with gastrointestinal diseases

•       Patients with gastroparesis or gastric emptying disorder ❌ Disable

•       Patients with chronic gastritis, gastric ulcers, or irritable bowel syndrome ⚠ Doctor's evaluation required

📌 Reason : Telborpeptide delays gastric emptying , which may worsen gastrointestinal diseases.

📌 4. People at high risk of hypoglycemia

•       Diabetic patients taking insulin or sulfonylurea hypoglycemic drugs ⚠ Dosage adjustment is required.

📌 Reason : While telpolide itself carries a low risk of hypoglycemia, its use in combination with insulin or hypoglycemic agents may increase the incidence of hypoglycemia , requiring close monitoring of blood glucose levels.

📌 5. Other special groups

•       Patients with severe liver and kidney dysfunction ❌ Disable

•       Teenagers under the age of 18 ❌ Banned (not approved by the FDA )

📌 Reason : The safety of telpolide has not been established in adolescents and individuals with severe liver or kidney dysfunction, and its use is not recommended .

💡 Conclusion: If you have a history of thyroid cancer, severe gastrointestinal disease, are pregnant, or have severe liver or kidney dysfunction, it is recommended to choose other weight loss programs.

 

3. Are you a suitable candidate for using telpoeptide? How can this be scientifically assessed?

📌 If you meet the following criteria, telpolide may be a suitable option for you:

 ✅ BMI ≥30 or BMI ≥27 with accompanying metabolic problems (diabetes, hypertension, fatty liver, etc.)

✅ Despite repeated attempts at dieting, exercise, and traditional medications, I have been unable to lose weight effectively.

✅ I have a habit of overeating and want to control my appetite.

✅ There is visceral fat accumulation (abdominal obesity).

✅ Hoping to achieve long-term and stable weight loss results

📌 If you fall into any of the following categories, you are not suitable to use telpolide:

❌ History of medullary thyroid carcinoma ( MTC ) or MEN 2

❌ Pregnant women and women trying to conceive

❌ Patients with gastroparesis and severe gastrointestinal diseases

❌ Patients with severe liver and kidney dysfunction

❌ Under 18 years old

💡 Final conclusion: Telpoeptide is suitable for most obese individuals who have difficulty losing weight, but not for pregnant women, those with a history of thyroid cancer, or patients with severe gastrointestinal diseases. Scientifically assess your own situation and choose the most suitable weight loss plan.